
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Page 29 of 100</i></p>
<p style="font-size: small; color: grey;"><i>ABAXIS_10k_029.pdf</i></p>
<p>On March 31, 2015, we completed the sale of our AVRL business to Antech. We have reclassified the assets, liabilities, results of operations and the gain on sale of AVRL in our consolidated balance sheets and statements of income for all periods presented to reflect them as discontinued operations. Previously reported financial information have been revised to reflect the reclassification of AVRL within our veterinary market segment as a discontinued operation. See Note 3 to the Consolidated Financial Statements in Part II, Item 8 of this report for additional information.</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="5">Year Ended March 31,</th>
	</tr>
	<tr>
		<th>2017</th>
		<th>2016</th>
		<th>2015</th>
		<th>2014</th>
		<th>2013</th>
	</tr>
	<tr>
		<td></td>
		<td colspan="5">(In thousands, except per share data)</td>
	</tr>
	<tr>
		<td>Statements of Income Data:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Continuing Operations:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Revenues</td>
		<td>$ 227,220</td>
		<td>$ 218,901</td>
		<td>$ 202,593</td>
		<td>$ 162,031</td>
		<td>$180,878</td>
	</tr>
	<tr>
		<td>Cost of revenues</td>
		<td>101,375</td>
		<td>95,649</td>
		<td>93,623</td>
		<td>78,081</td>
		<td>79,903</td>
	</tr>
	<tr>
		<td>Gross profit</td>
		<td>125,845</td>
		<td>123,252</td>
		<td>108,970</td>
		<td>83,950</td>
		<td>100,975</td>
	</tr>
	<tr>
		<td>Operating expenses:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Research and development</td>
		<td>19,795</td>
		<td>18,388</td>
		<td>16,327</td>
		<td>13,647</td>
		<td>13,577</td>
	</tr>
	<tr>
		<td>Sales and marketing</td>
		<td>45,249</td>
		<td>42,526</td>
		<td>42,147</td>
		<td>34,742</td>
		<td>43,800</td>
	</tr>
	<tr>
		<td>General and administrative</td>
		<td>16,314</td>
		<td>15,984</td>
		<td>16,192</td>
		<td>11,333</td>
		<td>12,825</td>
	</tr>
	<tr>
		<td>Gain from legal settlement</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
		<td>(17,250)</td>
	</tr>
	<tr>
		<td>Total operating expenses</td>
		<td>81,358</td>
		<td>76,898</td>
		<td>74,666</td>
		<td>59,722</td>
		<td>52,952</td>
	</tr>
	<tr>
		<td>Income from operations</td>
		<td>44,487</td>
		<td>46,354</td>
		<td>34,304</td>
		<td>24,228</td>
		<td>48,023</td>
	</tr>
	<tr>
		<td>Interest and other income (expense), net</td>
		<td>6,625</td>
		<td>793</td>
		<td>(1,262)</td>
		<td>994</td>
		<td>253</td>
	</tr>
	<tr>
		<td>Income from continuing operations before income tax provision</td>
		<td>51,112</td>
		<td>47,147</td>
		<td>33,042</td>
		<td>25,222</td>
		<td>48,276</td>
	</tr>
	<tr>
		<td>Income tax provision</td>
		<td>18,333</td>
		<td>16,073</td>
		<td>12,239</td>
		<td>8,993</td>
		<td>17,149</td>
	</tr>
	<tr>
		<td>Income from continuing operations</td>
		<td>$ 32,779</td>
		<td>$ 31,074</td>
		<td>$ 20,803</td>
		<td>$ 16,229</td>
		<td>$ 31,127</td>
	</tr>
	<tr>
		<td>Net income per share from continuing operations:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Basic</td>
		<td>$ 1.46</td>
		<td>$ 1.37</td>
		<td>$ 0.92</td>
		<td>$ 0.73</td>
		<td>$ 1.42</td>
	</tr>
	<tr>
		<td>Diluted</td>
		<td>$ 1.44</td>
		<td>$ 1.36</td>
		<td>$ 0.91</td>
		<td>$ 0.72</td>
		<td>$ 1.39</td>
	</tr>
	<tr>
		<td>Discontinued Operations:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Loss from discontinued operations, net of tax</td>
		<td>$ (63)</td>
		<td>$ (3)</td>
		<td>$ (1,154)</td>
		<td>$ (2,044)</td>
		<td>$ (3,668)</td>
	</tr>
	<tr>
		<td>Gain on sale of discontinued operations, net of tax</td>
		<td>$ —</td>
		<td>$ 559</td>
		<td>$ 7,682</td>
		<td>$</td>
		<td>$ —</td>
	</tr>
	<tr>
		<td>Net income (loss) per share from discontinued operations:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Basic</td>
		<td>$ (0.01)</td>
		<td>$ 0.03</td>
		<td>$ 0.29</td>
		<td>$ (0.09)</td>
		<td>$ (0.17)</td>
	</tr>
	<tr>
		<td>Diluted</td>
		<td>$ —</td>
		<td>$ 0.02</td>
		<td>$ 0.29</td>
		<td>$ (0.09)</td>
		<td>$ (0.16)</td>
	</tr>
	<tr>
		<td>Consolidated Operations:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Net income</td>
		<td>$ 32,716</td>
		<td>$ 31,630</td>
		<td>$ 27,331</td>
		<td>$ 14,185</td>
		<td>$ 27,459</td>
	</tr>
	<tr>
		<td>Net income per share:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Basic</td>
		<td>$ 1.45</td>
		<td>$ 1.40</td>
		<td>$ 1.21</td>
		<td>$ 0.64</td>
		<td>$ 1.25</td>
	</tr>
	<tr>
		<td>Diluted</td>
		<td>$ 1.44</td>
		<td>$ 1.38</td>
		<td>$ 1.20</td>
		<td>$ 0.63</td>
		<td>$ 1.23</td>
	</tr>
	<tr>
		<td>Shares used in the calculation of net income per share:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Weighted average common shares outstanding - basic</td>
		<td>22,515</td>
		<td>22,661</td>
		<td>22,497</td>
		<td>22,270</td>
		<td>21,946</td>
	</tr>
	<tr>
		<td>Weighted average common shares outstanding - diluted</td>
		<td>22,797</td>
		<td>22,883</td>
		<td>22,787</td>
		<td>22,575</td>
		<td>22,381</td>
	</tr>
	<tr>
		<td>Cash dividends declared per share</td>
		<td>$ 0.52</td>
		<td>$ 0.44</td>
		<td>$ 0.40</td>
		<td>$ —</td>
		<td>$ 1.00</td>
	</tr>
</table>
<p style="font-size: small; color: grey;"><i>29</i></p>
<p>TABLE OF CONTENTS</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="5">Year Ended March 31,</th>
	</tr>
	<tr>
		<th>2017</th>
		<th>2016</th>
		<th>2015</th>
		<th>2014</th>
		<th>2013</th>
	</tr>
	<tr>
		<td></td>
		<td colspan="5">(In thousands)</td>
	</tr>
	<tr>
		<td>Consolidated Balance Sheets Data <sup>(1)</sup> :</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Cash and cash equivalents</td>
		<td>$ 91,332</td>
		<td>$ 88,323</td>
		<td>$ 107,015</td>
		<td>$ 73,589</td>
		<td>$ 54,910</td>
	</tr>
	<tr>
		<td>Short-term investments</td>
		<td>51,561</td>
		<td>41,474</td>
		<td>26,109</td>
		<td>29,102</td>
		<td>23,354</td>
	</tr>
	<tr>
		<td>Working capital</td>
		<td>199,735</td>
		<td>183,026</td>
		<td>168,576</td>
		<td>148,553</td>
		<td>132,944</td>
	</tr>
	<tr>
		<td>Long-term investments</td>
		<td>22,171</td>
		<td>22,458</td>
		<td>24,181</td>
		<td>18,491</td>
		<td>17,000</td>
	</tr>
	<tr>
		<td>Total assets</td>
		<td>305,646</td>
		<td>271,380</td>
		<td>269,064</td>
		<td>217,380</td>
		<td>201,763</td>
	</tr>
</table>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RP ... 7/23/2018</i></p>

</body>
</html>
